TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19329546

Group type: EXPERIMENTAL
Intervention: 300 mg/74 mg BZP/TFMPP
Number of subjects: 35

Group type: COMPARATOR
Intervention: 57.6 g (6 units) alcohol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BZP/TFMPP alone or with alcohol
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BZP/TFMPP
Number of subjects: 35
Study: 18622632

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1200 mg/m(2) per day (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA) 4-5 mg/kg per day (n = 12)
Number of subjects: 24
Study: 15882244

Group type: EXPERIMENTAL
Intervention: Lansoprazole, amoxicillin and clarithromycin (antibiotic group)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Lansoprazole and identical antibiotic placebos (control group)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Antibiotic group
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 157
Study: 12970012

Group type: EXPERIMENTAL
Intervention: Early mobilization (EM)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 458
Study: 11005367

Group type: EXPERIMENTAL
Intervention: Anticipatory guidance with early literacy development and provision of books at well-child visits (WCV)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Anticipatory guidance with early literacy development and provision of books at WCV
Number of subjects: 352

Group type: COMPARATOR
Intervention: Anticipatory guidance without book provision at WCV
Number of subjects: 352
Study: 8843174

Group type: EXPERIMENTAL
Intervention: Parenteral fish oil (FO) at 0.15 g/kg/d for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soybean oil (SO) at 1.0 g/kg/d for 5 days
Number of subjects: 20
Study: 1509577

Group type: EXPERIMENTAL
Intervention: Foot zone therapy (10 sessions of 1 hour each at intervals of one week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uniform clinical care without placebo foot zone therapy
Number of subjects: 30
Study: 6373340

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (100 mg orally)
Number of subjects: 6
Study: 29789243

Group type: EXPERIMENTAL
Intervention: MenACWY-TT and AS04-HPV16/18 co-administered
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: MenACWY-TT, AS04-HPV16/18 and Tdap co-administered
Number of subjects: 1300

Group type: COMPARATOR
Intervention: MenACWY-TT alone
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Tdap and AS04-HPV16/18 co-administered
Number of subjects: 1300
Study: 26450445

Group type: EXPERIMENTAL
Intervention: adalimumab
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: etanercept
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ustekinumab
Number of subjects: 42
Study: 24833067

Group type: EXPERIMENTAL
Intervention: Early escape per patient choice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early escape per protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional crossover design
Number of subjects: 0
Study: 23390831

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No mechanical bowel preparation
Number of subjects: 85
Study: 20212302

Group type: EXPERIMENTAL
Intervention: Ask Me 3 (AM3) health communication program
Number of subjects: 834

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 834
Study: 18349394

Group type: EXPERIMENTAL
Intervention: Irinotecan/FU/FA combination therapy
Number of subjects: 2691
Study: 16105610

Group type: EXPERIMENTAL
Intervention: levofloxacin 0.5% eyedrops
Number of subjects: 69

Group type: COMPARATOR
Intervention: ofloxacin 0.3% eyedrops
Number of subjects: 69
Study: 12509599

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 21
Study: 11498702

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g every 8 or 12 hours)
Number of subjects: 45
Study: 9065256

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight (LMW) heparins
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-dose heparin prophylaxis (fractionated or unfractionated)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Spinal/epidural anaesthesia
Number of subjects: 12
Study: 1684556

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0
Study: 6881119

Group type: EXPERIMENTAL
Intervention: Bromocriptine 15 mg/day plus cleansing enemas
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Bromocriptine 30 mg/day plus cleansing enemas
Number of subjects: 4

Group type: COMPARATOR
Intervention: Neomycin 6 g/day plus cleansing enemas (standard therapy)
Number of subjects: 4
Study: 30672248

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment at Baihui (GV 20), Fengfu (GV 16), Shenting (GV 24), Taiyang (EX‐HN 5), Shangyintang (Extra 3), Dazhong (KI 14); EA applied at Taiyang (EX‐HN 5), Baihui (GV 20), Shenting (GV 24) with dilatational wave, 10 Hz/50 Hz frequency, 0.5 to 5.0 mA intensity, once every two days, three treatments per week for 12 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Donepezil hydrochloride tablets, once a day before sleep for 12 weeks.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups evaluated at baseline, 12 weeks, and 24 weeks after treatment.
Number of subjects: 40
Study: 28230390

Group type: EXPERIMENTAL
Intervention: Deprexis (Internet treatment for depression) for 8 weeks
Number of subjects: 376

Group type: COMPARATOR
Intervention: Waitlist control (8-week delay)
Number of subjects: 376
Study: 24467878

Group type: EXPERIMENTAL
Intervention: Hypocaloric feeding (60% of estimated requirements)
Number of subjects: 50
Study: 22385554

Group type: EXPERIMENTAL
Intervention: Complementary delirium e-learning course
Number of subjects: 0
Study: 19179295

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 1937

Group type: EXPERIMENTAL
Intervention: Factors evaluated (body weight, diabetes, positive immune response)
Number of subjects: 1937
Study: 17937685

Group type: EXPERIMENTAL
Intervention: Basic developmental care (standardized nests and incubator covers)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: NIDCAP (Newborn Individualized Developmental Care and Assessment Program)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 283
Study: 11151439

Group type: EXPERIMENTAL
Intervention: Hypnotherapy (six sessions of individual hypnotherapy)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Audiotape (therapeutic audiotape)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups (Hypnotherapy and Audiotape)
Number of subjects: 52
Study: 9190123

Group type: EXPERIMENTAL
Intervention: Normal Glycogen (NG)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Depleted Glycogen (DG)
Number of subjects: 6
Study: 1398561

Group type: EXPERIMENTAL
Intervention: High doses of diethylstilbestrol
Number of subjects: 1646

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1646
Study: 2993946

Group type: EXPERIMENTAL
Intervention: ACTH 4‐9 analogue (ORG 2766), 80 mg daily during 14‐28 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29982627

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) system
Number of subjects: 7914

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 7914

Group type: EXPERIMENTAL
Intervention: CDS
Number of subjects: 7914

Group type: COMPARATOR
Intervention: UC
Number of subjects: 7914
Study: 26453639

Group type: EXPERIMENTAL
Intervention: T&E+laser
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: T&E
Number of subjects: 372

Group type: COMPARATOR
Intervention: PRN (control)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: T&E+laser and T&E
Number of subjects: 372
Study: 24101698

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (40 IU)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 29
Study: 22587616

Group type: EXPERIMENTAL
Intervention: Higher RBP4 levels
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: RBP4 levels in the bottom and upper quartiles
Number of subjects: 709

Group type: EXPERIMENTAL
Intervention: Squared RBP4 term in regression modeling
Number of subjects: 709
Study: 20191360

Group type: EXPERIMENTAL
Intervention: Taranabant 2-8 mg
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 18541569

Group type: EXPERIMENTAL
Intervention: Nucleotide-supplemented formula (31 mg/L)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Breastfed (reference group)
Number of subjects: 106
Study: 15838899

Group type: EXPERIMENTAL
Intervention: Temporary sacral nerve stimulation (SNS)
Number of subjects: 13
Study: 12380632

Group type: EXPERIMENTAL
Intervention: Glyburide/metformin 1.25 mg/250 mg tablets BID for HbA1c < 9%; Glyburide/metformin 2.5 mg/500 mg tablets BID for HbA1c >= 9%.
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Glyburide/metformin tablets.
Number of subjects: 828
Study: 10486674

Group type: EXPERIMENTAL
Intervention: Obese, hypertensive, with hyperinsulinemia
Number of subjects: 77

Group type: COMPARATOR
Intervention: Obese, hypertensive, without hyperinsulinemia
Number of subjects: 77

Group type: COMPARATOR
Intervention: Non-obese, hypertensive, without hyperinsulinemia
Number of subjects: 77

Group type: COMPARATOR
Intervention: Obese, normotensive, without hyperinsulinemia
Number of subjects: 77
Study: 9019702

Group type: EXPERIMENTAL
Intervention: Special physiotherapy and learning to avoid unaesthetic postures through appropriate muscular control
Number of subjects: 0
Study: 1769141

Group type: EXPERIMENTAL
Intervention: Preparation A: rhEPO 2000 IU in 1 ml (Cilag)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Preparation B: rhEPO 2000 IU in 1 ml (Boehringer Mannheim)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% saline 1 ml (placebo)
Number of subjects: 18
Study: 31272569

Group type: EXPERIMENTAL
Intervention: Nitrate use
Number of subjects: 3417

Group type: COMPARATOR
Intervention: No nitrate use (control)
Number of subjects: 3417
Study: 28081945

Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide (FAc) 0.2 μg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide (FAc) 0.5 μg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide (FAc) 0.2 μg/day and 0.5 μg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 25934661

Group type: EXPERIMENTAL
Intervention: Serum α-tocopherol (αT) quartiles
Number of subjects: 4708

Group type: EXPERIMENTAL
Intervention: Serum γ-tocopherol (γT) quartiles
Number of subjects: 4708
Study: 23463655

Group type: COMPARATOR
Intervention: Vitamin D3 (400 IU/d)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (10,000 IU/d)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (40,000 IU/d)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (all doses)
Number of subjects: 63
Study: 21215636

Group type: EXPERIMENTAL
Intervention: Elliptical training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Treadmill walking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stationary cycling
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Overground walking
Number of subjects: 10
Study: 17969902

Group type: EXPERIMENTAL
Intervention: Penqiangyan Granule (PG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Penyanjing Granule (Control)
Number of subjects: 60
Study: 11889008

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 9014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9014
Study: 10437863

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control (placebo plus conventional antihypertensive therapy)
Number of subjects: 186
Study: 7767512

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 400 micrograms/day for 7 months
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 2178484

Group type: EXPERIMENTAL
Intervention: 0.5% prilocaine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 0.75% prilocaine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1.0% prilocaine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 300
Study: 6104610

Group type: EXPERIMENTAL
Intervention: H1 antihistamine (chlorpheniramine)
Number of subjects: 5

Group type: COMPARATOR
Intervention: H2 antihistamines
Number of subjects: 5
Study: 31788913

Group type: EXPERIMENTAL
Intervention: Guiding personal self-disclosure
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Personal reassuring self-disclosure
Number of subjects: 348

Group type: COMPARATOR
Intervention: Redirecting non-disclosure with reassuring intention
Number of subjects: 348

Group type: COMPARATOR
Intervention: Literal responses
Number of subjects: 348
Study: 30741025

Group type: EXPERIMENTAL
Intervention: Shen Cao granules (10 g once daily)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 28937980

Group type: EXPERIMENTAL
Intervention: Probiotic mixture composed of five Lactobacilli strains and two Bifidobacteria strains, administered once a day for 60 days
Number of subjects: 21
Study: 25740863

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 3044

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 3044
Study: 23591697

Group type: EXPERIMENTAL
Intervention: Traffic-related air pollution at high noise level (>65.6 dB[A])
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traffic-related air pollution at low noise level (≤ 65.6 dB[A])
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Black carbon (BC) at high noise level
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carbon monoxide (CO) at high noise level
Number of subjects: 40
Study: 21644092

Group type: EXPERIMENTAL
Intervention: Short-segment posterior instrumentation (Group 1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Long-segment posterior instrumentation (Group 2)
Number of subjects: 80
Study: 19590222

Group type: EXPERIMENTAL
Intervention: Voice Massage (VM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Voice Hygiene Lecture (VHL)
Number of subjects: 60
Study: 16885491

Group type: EXPERIMENTAL
Intervention: 30-minute counseling session on breastfeeding technique
Number of subjects: 211
Study: 15309418

Group type: EXPERIMENTAL
Intervention: Fermented milk (two 100mL portions per day)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Semi-skimmed milk (one glass per day, control group)
Number of subjects: 136
Study: 11359382

Group type: EXPERIMENTAL
Intervention: Intermittent short courses of cyclosporin (Neoral)
Number of subjects: 255
Study: 9160938

Group type: EXPERIMENTAL
Intervention: Lateral electrical surface stimulation
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Observation only
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Bracing for eight hours per day
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Bracing for sixteen hours per day
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Bracing for twenty-three hours per day
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Milwaukee brace
Number of subjects: 1910

Group type: COMPARATOR
Intervention: Bracing for eight or sixteen hours per day
Number of subjects: 1910
Study: 8483862

Group type: EXPERIMENTAL
Intervention: Intensive teacher training
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Brief teacher training
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Principal intervention
Number of subjects: 1232

Group type: COMPARATOR
Intervention: No principal intervention
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Program delivery integrity
Number of subjects: 1232
Study: 3307386

Group type: EXPERIMENTAL
Intervention: Monocomponent pertussis toxoid vaccine (JNIH‐7)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Two-component vaccine (JNIH‐6)
Number of subjects: 255
Study: 30326609

Group type: EXPERIMENTAL
Intervention: Micronutrient Powders (MNP) with low iron dose (6 mg/serving)
Number of subjects: 1172
Study: 27568011

Group type: EXPERIMENTAL
Intervention: Balance-based exergaming intervention using the Kinect sensor
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 20
Study: 24584550

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 22606361

Group type: EXPERIMENTAL
Intervention: Low plasma ferritin (<30 µg/L)
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Low plasma ferritin (<30 µg/L) among HIV-infected patients
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: High plasma ferritin (>150 µg/L for women and >200 µg/L for men)
Number of subjects: 705
Study: 20837597

Group type: EXPERIMENTAL
Intervention: Nucleotide-supplemented formula (31 mg/L)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control formula (without nucleotide supplementation)
Number of subjects: 301
Study: 18756850

Group type: EXPERIMENTAL
Intervention: Fluoride level in drinking water sources (0.02 to 0.03 ppm)
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Dental caries prevalence
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Mean DMFT among 19-year-old children
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Caries experience
Number of subjects: 955
Study: 16047554

Group type: EXPERIMENTAL
Intervention: Chunghyul‐dan 1200 mg once a day for 2 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 28
Study: 12145067

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 microg (IT 100 group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 200 microg (IT 200 group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Epidural morphine 3 mg (Epidural group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study: 10329080

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 533

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 533
Study: 7757315

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (400 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2317162

Group type: EXPERIMENTAL
Intervention: High fat, high cholesterol diet
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Low fat, low cholesterol diet intervention
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Switchback diet
Number of subjects: 110
Study: 7461011

Group type: EXPERIMENTAL
Intervention: fenoterol (1, 2, or 4 microgram/min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ritodrine (100, 200, or 400 microgram/min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: fenoterol and ritodrine
Number of subjects: 24
Study: 31915207

Group type: EXPERIMENTAL
Intervention: Minimally invasive endoscopic ICH evacuation
Number of subjects: 100
Study: 30086761

Group type: EXPERIMENTAL
Intervention: Canine Bud Extraction (CBE)
Number of subjects: 298
Study: 27332902

Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 1214

Group type: COMPARATOR
Intervention: AVD (omit bleomycin)
Number of subjects: 1214

Group type: EXPERIMENTAL
Intervention: BEACOPP (for patients with positive PET findings)
Number of subjects: 1214

Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 1214
Study: 24952307

Group type: EXPERIMENTAL
Intervention: Abagovomab
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 23117550

Group type: EXPERIMENTAL
Intervention: Allogeneic MSCs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Autologous MSCs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both Allogeneic and Autologous MSCs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose concentration MSCs (20 million cells)
Number of subjects: 30
Study: 21176657

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 60
Study: 18728909

Group type: EXPERIMENTAL
Intervention: rapidly forward‐rotating shift system
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: flexible shift system
Number of subjects: 84

Group type: COMPARATOR
Intervention: old shift system
Number of subjects: 84
Study: 15869128

Group type: EXPERIMENTAL
Intervention: Early postoperative feeding
Number of subjects: 51

Group type: COMPARATOR
Intervention: Traditional postoperative feeding
Number of subjects: 51
Study: 12872612

Group type: EXPERIMENTAL
Intervention: Fixed combination bi-layer tablet (Quadroplus)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tablets containing solely spirapril hydrochloride monohydrate (Quadropril)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (produced exclusively for study medication)
Number of subjects: 12
Study: 11044578

Group type: EXPERIMENTAL
Intervention: Androgen receptor mRNA expression in hippocampal tissue
Number of subjects: 42
Study: 8644545

Group type: EXPERIMENTAL
Intervention: Prick test with 10% fluorescein solution
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Prick test with 1.0% fluorescein solution
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Intradermal skin test with 10% fluorescein solution
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Intradermal skin test with 0.1% fluorescein solution
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Fluorescein angiography (FAG)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Adverse reactions (nausea, cough, cold sweat, urticaria, shock)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Typical anaphylactoid shock
Number of subjects: 1500
Study: 1338232

Group type: EXPERIMENTAL
Intervention: Brachytherapy
Number of subjects: 35
Study: 6704973

Group type: EXPERIMENTAL
Intervention: Autologous tumor cells plus Bacillus Calmette‐Guérin vaccine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal tissue control (autologous normal mucosa)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonimmunized control patients
Number of subjects: 24